BiotechTube

Esomeprazole Magnesium + Lansoprazole

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn, Gastroesophageal Reflux Disease

Trial Timeline

Jun 1, 2002 → Feb 1, 2003

NCT ID
NCT00637845

About Esomeprazole Magnesium + Lansoprazole

Esomeprazole Magnesium + Lansoprazole is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00637845. Target conditions include Heartburn, Gastroesophageal Reflux Disease.

What happened to similar drugs?

6 of 14 similar drugs in Heartburn were approved

Approved (6) Terminated (0) Active (8)
✅esomeprazole 40 mgAstraZenecaApproved
✅Esomeprazole magnesium (Nexium)AstraZenecaApproved
✅Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
✅Esomeprazole 20 mg + PlaceboPfizerApproved
✅Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
✅Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
🔄rabeprazole sodiumEisaiPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00637845ApprovedCompleted

Competing Products

20 competing products in Heartburn

See all competitors
ProductCompanyStageHype Score
rabeprazole sodiumEisaiPhase 3
40
rabeprazole sodium + placeboEisaiPhase 3
40
Rabeprazole sodiumEisaiPre-clinical
26
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
29
esomeprazole 40 mgAstraZenecaApproved
43
Esomeprazole magnesium (Nexium)AstraZenecaApproved
43
EsomeprazoleAstraZenecaPhase 3
40
EsomeprazoleAstraZenecaPhase 3
40
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
43
Famotidine FCT + Famotidine CTMerckPhase 1
29
LanzoprazoleNovartisPhase 3
40
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
40
LansoprazoleNovartisPhase 3
40
TegaserodNovartisPhase 3
40
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + PlaceboNovartisPhase 2
35
Esomeprazole 20 mg + PlaceboPfizerApproved
43
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)BayerPhase 1
26
omeprazole/sodium bicarbonate + omeprazole magnesiumBayerPhase 1
26
Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
40
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
40